Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
702 | 3 | HISTAMINE H 3 RECEPTOR//HISTAMINE//THIOPERAMIDE | 7133 |
2115 | 2 | HISTAMINE H 3 RECEPTOR//HISTAMINE//THIOPERAMIDE | 5482 |
788 | 1 | HISTAMINE H 3 RECEPTOR//THIOPERAMIDE//HISTAMINE | 3096 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | HISTAMINE H 3 RECEPTOR | authKW | 2683999 | 10% | 89% | 295 |
2 | THIOPERAMIDE | authKW | 1381467 | 5% | 88% | 155 |
3 | HISTAMINE | authKW | 1129930 | 26% | 14% | 807 |
4 | H 3 RECEPTOR | authKW | 1105428 | 4% | 83% | 131 |
5 | R ALPHA METHYLHISTAMINE | authKW | 544307 | 2% | 82% | 65 |
6 | H 3 ANTAGONISTS | authKW | 390297 | 1% | 91% | 42 |
7 | ALPHA FLUOROMETHYLHISTIDINE | authKW | 381052 | 2% | 80% | 47 |
8 | CLOBENPROPIT | authKW | 299556 | 1% | 89% | 33 |
9 | H 3 RECEPTOR ANTAGONIST | authKW | 277576 | 1% | 91% | 30 |
10 | CIPROXIFAN | authKW | 264990 | 1% | 96% | 27 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 15613 | 42% | 0% | 1294 |
2 | Neurosciences | 11915 | 37% | 0% | 1139 |
3 | Chemistry, Medicinal | 3615 | 11% | 0% | 332 |
4 | Behavioral Sciences | 1804 | 6% | 0% | 181 |
5 | Psychology, Biological | 186 | 1% | 0% | 31 |
6 | Physiology | 151 | 3% | 0% | 106 |
7 | Chemistry, Organic | 150 | 5% | 0% | 150 |
8 | Psychiatry | 133 | 4% | 0% | 109 |
9 | Cell Biology | 110 | 5% | 0% | 162 |
10 | Immunology | 90 | 5% | 0% | 140 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | UNITE NEUROBIOL PHARMACOL MOL | 224292 | 1% | 48% | 46 |
2 | PAUL BROCA | 113663 | 1% | 31% | 36 |
3 | U109 | 104253 | 1% | 41% | 25 |
4 | NEUROBIOL PHARMACOL MOL | 84813 | 0% | 83% | 10 |
5 | R4MN | 81416 | 0% | 67% | 12 |
6 | LGCR SMRPD CHEM | 52342 | 0% | 86% | 6 |
7 | TECHNOL BIOTECHNOL DRUGS | 48015 | 1% | 20% | 24 |
8 | U573 | 43187 | 0% | 28% | 15 |
9 | DIP FARMACOL PRECLIN CLIN | 32568 | 0% | 80% | 4 |
10 | BIOMED ANAT | 29495 | 1% | 10% | 30 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INFLAMMATION RESEARCH | 53108 | 4% | 4% | 122 |
2 | AGENTS AND ACTIONS | 41816 | 4% | 4% | 115 |
3 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 8271 | 2% | 1% | 71 |
4 | EUROPEAN JOURNAL OF PHARMACOLOGY | 7893 | 5% | 1% | 150 |
5 | NEUROPHARMACOLOGY | 6008 | 2% | 1% | 76 |
6 | METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 5878 | 1% | 2% | 39 |
7 | JOURNAL OF NEUROCHEMISTRY | 4790 | 3% | 0% | 101 |
8 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 4786 | 4% | 0% | 112 |
9 | BRITISH JOURNAL OF PHARMACOLOGY | 3883 | 3% | 0% | 84 |
10 | BEHAVIOURAL BRAIN RESEARCH | 3513 | 2% | 1% | 62 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HISTAMINE H 3 RECEPTOR | 2683999 | 10% | 89% | 295 | Search HISTAMINE+H+3+RECEPTOR | Search HISTAMINE+H+3+RECEPTOR |
2 | THIOPERAMIDE | 1381467 | 5% | 88% | 155 | Search THIOPERAMIDE | Search THIOPERAMIDE |
3 | HISTAMINE | 1129930 | 26% | 14% | 807 | Search HISTAMINE | Search HISTAMINE |
4 | H 3 RECEPTOR | 1105428 | 4% | 83% | 131 | Search H+3+RECEPTOR | Search H+3+RECEPTOR |
5 | R ALPHA METHYLHISTAMINE | 544307 | 2% | 82% | 65 | Search R+ALPHA+METHYLHISTAMINE | Search R+ALPHA+METHYLHISTAMINE |
6 | H 3 ANTAGONISTS | 390297 | 1% | 91% | 42 | Search H+3+ANTAGONISTS | Search H+3+ANTAGONISTS |
7 | ALPHA FLUOROMETHYLHISTIDINE | 381052 | 2% | 80% | 47 | Search ALPHA+FLUOROMETHYLHISTIDINE | Search ALPHA+FLUOROMETHYLHISTIDINE |
8 | CLOBENPROPIT | 299556 | 1% | 89% | 33 | Search CLOBENPROPIT | Search CLOBENPROPIT |
9 | H 3 RECEPTOR ANTAGONIST | 277576 | 1% | 91% | 30 | Search H+3+RECEPTOR+ANTAGONIST | Search H+3+RECEPTOR+ANTAGONIST |
10 | CIPROXIFAN | 264990 | 1% | 96% | 27 | Search CIPROXIFAN | Search CIPROXIFAN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |